Acentra Health Appoints Ezmeralda Sager as Chief Transformation OfficerIndustry changemaker to drive transformation and operational improvements in the development and delivery of the company’s healthcare products, solutions, and services
Copia Power and Arizona Public Service (APS) Enter Into 20-Year Power Purchase Agreements for Large-Scale Solar and Storage Energy CampusPHOENIX, ARIZONA / ACCESS Newswire / January 17, 2025 / Copia Power ("Copia") today announced the execution of two Power Purchase Agreements ("PPAs") with Arizona Public Service Company ("APS") for Phase I and Phase II of the Maricopa Energy Center project ("Maricopa"), a 550 MW solar energy generating facility and 2,200 MWh battery energy storage facility located in Maricopa County, AZ. The project is scheduled to reach commercial operation in multiple phases between 2026-2027. Once operational, Maricopa will be the single-largest solar and energy storage project in Arizona.
Acentra Health’s Independent Medical Review Division Earns Accreditation from Leading Care Quality and Safety OrganizationConsecutive accreditations from URAC spanning 24 years underscore the company’s unwavering compliance with rigorous standards for independent medical reviews
TJC Closes Second Continuation Fund of $2.1 Billion Led by AlpInvest
TJC LP (“TJC” or “the Firm”), a middle-market private equity firm investing primarily in North American businesses, today announced the close of its second continuation fund (the “Continuation Fund”) at $2.1 billion, which will be an extension of The Resolute Fund III, L.P. (“Resolute III”) and include an asset jointly owned with The Resolute Fund IV, L.P. (“Resolute IV”).
Acentra Health Earns Recertification to ISO 9001:2015 Standard for its Quality Management SystemAdherence to rigorous certification standards reinforces Acentra Health’s client-first commitment to delivering maximum value and impact with high quality solutions and services
Unlock Private Equity Opportunities for All InvestorsThe Invesco Global Listed Private Equity ETF is a way to indirectly access private equity investments without specialized credentials.
Advance Auto Parts Eyes Long-Term Growth Despite Q2 HurdlesAdvance Auto Parts streamlines its business and confronts economic headwinds with strategic initiatives to drive future growth.
Baxter Announces Definitive Agreement to Divest Its Vantive Kidney Care Segment to Carlyle for $3.8 Billion
Baxter International Inc. (
NYSEBAX), a global medtech leader, and funds managed by global investment firm Carlyle
NASDAQ:CGNASDAQCG)
Quantum Capital Group to Acquire Cogentrix from Carlyle for $3 BillionCogentrix Platform Consists of 11 Natural Gas-Fired Power Plants, Comprising 5.3 Gigawatts of Efficient and Reliable Capacity Across Key U.S. Markets
Acentra Health Names Brett Barton as Senior Vice President of Client ExperienceMCLEAN, Va., July 23, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, has named Brett Barton as Senior Vice President (SVP) of Client Experience. In this newly created role, Barton will represent the voice of the client across multiple touchpoints to deliver an exceptional experience that supports continued growth for the company and elevates the Acentra Health brand.
Acentra Health Names Ryan Bosch, MD, as Executive Vice President, Chief Health and Informatics OfficerBosch will oversee the company's work to accelerate the delivery of clinically evidenced solutions that improve health outcomes and advance health equity at scale
Acentra Health Names Heather Adamson as Senior Vice President of MarketingMCLEAN, Va., June 18, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, today announced that Heather Adamson has joined the company as Senior Vice President of Marketing. In this role, Adamson will oversee the development and implementation of the company’s marketing strategy, creating data-driven frameworks to support the company’s brand, content, digital, and product marketing programs. She reports to Acentra Health’s Chief Growth Officer.
Acentra Health Named ‘Corporate Growth Company of the Year’ by ACG National CapitalMCLEAN, Va., June 11, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, is the winner of the Association of Corporate Growth (ACG) National Capital chapter’s Corporate Growth Award for companies over $250 million in annual revenue. ACG’s growth awards honor the Washington D.C., region’s fastest growing companies and business leaders whose deals created significant corporate value in 2023 through mergers and acquisitions, strategic partnerships, organic growth, and capital financing.
Acentra Health Executive Vice President & Chief Strategy Officer Verlon Johnson Appointed Chair of Medicaid and CHIP Payment Access CommissionMCLEAN, Va., May 02, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a Virginia-based technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, announced today that Acentra Health Executive Vice President and Chief Strategy Officer Verlon Johnson, MPA, has been appointed Chair of the Medicaid and CHIP Payment and Access Commission (MACPAC) by the U.S. Government Accountability Office (GAO). In addition, she was reappointed to serve a second consecutive three-year term as a MACPAC commissioner.
Clinical Collaboration Agreement between Teva and Launch Therapeutics to Accelerate Development of Dual-Action Asthma Rescue Inhaler (ICS-SABA/TEV-’248) Respiratory Program; Teva and Abingworth Enter Strategic Development Funding Agreement
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Launch Therapeutics, Inc., today announced a clinical collaboration agreement to further accelerate the clinical research program of Teva’s ICS-SABA (TEV-‘248). Teva and Abingworth, a leading international life sciences investment group, part of global investment firm Carlyle (
NASDAQCG), today also announced a strategic development funding agreement in which Abingworth provides Teva up to $150 million to offset Teva’s ICS/SABA (TEV-‘248) program costs.
Grant Christie Joins Acentra Health as Senior Vice President of Market Strategy and SolutionsMCLEAN, Va., March 26, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a Virginia-based technology solutions and clinical services company dedicated to helping government healthcare agencies accelerate better health outcomes, announced the appointment of Grant Christie as Senior Vice President, Market Strategy and Solutions. A seasoned information technology solutions and services veteran with extensive experience in the public sector and commercial healthcare spaces, Christie will play a pivotal role in aligning Acentra Health’s portfolio of products, solutions, and tech-enabled services to meet the needs and demands of the healthcare market and promote continued strong growth for the company.
SER Welcomes New Investment from TA to Accelerate Growth
SER (the “Company”), a leading global Intelligent Content Automation (“ICA”) software vendor in the Enterprise Content Management (“ECM”) market, today announced that TA Associates (“TA”), a leading global private equity firm, has agreed to make a strategic growth investment in the Company. SER and Carlyle, an investor in SER since 2018, welcome TA as the new lead investor.
Daniel Hallenbeck Joins Acentra Health as Vice President of Strategy and Strategic PartnershipsMCLEAN, Va., Jan. 31, 2024 (GLOBE NEWSWIRE) -- Acentra Health, a Virginia-based technology services and solutions company dedicated to helping government healthcare agencies accelerate better health outcomes, announced the appointment of Daniel Hallenbeck as Vice President (VP) of Strategy and Strategic Partnerships. A nationally recognized expert in Medicaid Enterprise Systems and a former New York State (NYS) Medicaid Chief Technology Officer (CTO), Hallenbeck will serve as an integral member of the Acentra Health Leadership Team, supporting the Chief Strategy Officer in the development and execution of the company’s strategy around value creation, digital health, and mergers and acquisitions.
Acentra Health Announces Acquisition of EAP Consultants, LLCCombined company to drive improvements in mental health outcomes through technology enablement, data analytics, and clinical expertise
Acentra Health Awarded North Carolina’s $56.9M Comprehensive Independent Assessment Entity Contract to Enable Timelier Access to Medicaid Long-Term Services and SupportsMCLEAN, Va., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Acentra Health, formed by the merger of CNSI and Kepro, announced today that the North Carolina (NC) Department of Health and Human Services (DHHS) awarded the company the Comprehensive Independent Assessment Entity (CIAE) contract for the NC Medicaid program. As the CIAE, Acentra Health will implement and operate the state’s new clinical delivery model, the NC Medicaid Linking Individuals & Families for Long Term Services and Supports (NCLIFTSS), creating a single point of access for multiple long term services and supports (LTSS) programs. NCLIFTSS will enable timelier access for beneficiaries deemed eligible to receive Medicaid LTSS and create a smoother referral process for providers. The NCLIFTSS contract includes a three-year base term valued at $56.9 million and two one-year extension options totaling $41.9 million.
